A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases

Journal of Cell Science

Volumn 120, Issue 10, 2007, Pages 1707-1716

  Mandemakers, Wim ^a   Morais, Vanessa A ^a   De Strooper, Bart ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Apoptosis; Mitochondria; Mitochondrial dynamics; Neurodegenerative; Oxidative stress; OXPHOS; Parkinson disease

Indexed keywords

ALPHA SYNUCLEIN; CALCIUM ION; DJ 1 PROTEIN; DOPAMINE; GENE PRODUCT; LEUCINE RICH REPEAT KINASE 2; MITOCHONDRIAL PROTEIN; MUTANT PROTEIN; PARKIN; PHOSPHOTRANSFERASE; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CELL FUNCTION; CELL STRUCTURE; CELL TRANSPORT; CYTOLOGY; DEGENERATIVE DISEASE; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOPAMINERGIC NERVE CELL; ENERGY METABOLISM; GENE DUPLICATION; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC CODE; GENETIC PREDISPOSITION; HUMAN; LIPID PEROXIDATION; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NERVE CELL LESION; NERVE CELL PLASTICITY; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION;

ANIMALS; APOPTOSIS; CENTRAL NERVOUS SYSTEM; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; MUTATION; NEURODEGENERATIVE DISEASES; NEURONS; OXIDATIVE STRESS; PARKINSON DISEASE;

EID: 34250624810     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.03443     Document Type: Article

References (151)

1. Abbas, N., Lucking, C. B., Ricard, S., Durr, A., Bonifati, V., De Michele, G., Bouley, S., Vaughan, J. R., Gasser, T., Marconi, R. et al. (1999). A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease. Hum. Mol. Genet. 8, 567-574.
2. Abeliovich, A., Schmitz, Y., Farinas, I, Choi-Lundberg, D., Ho, W. H., Castillo, P. E., Shinsky, N., Verdugo, J. M., Armanini, M., Ryan, A. et al. (2000). Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25, 239-252.
3. Autere, J., Moilanen, J. S., Finnila, S., Soininen, H., Mannermaa, A., Hartikainen, P., Hallikainen, M. and Majamaa, K. (2004). Mitochoadrial DNA polymorphisms as risk factors for Parkinson's disease and Parkinson's disease dementia. Hum. Genet. 115, 29-35.
4. Bae, B. L, Xu, H., Igarashi, S., Fujimuro, M., Agrawal, N., Taya, Y., Hayward, S. D., Moran, T. H., Montell, C., Ross, C. A. et al. (2005). p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease. Neuron 47, 29-41.
5. Bandopadhyay, R., Kingsbury, A. E., Cookson, M. R., Reid, A. R., Evans, I. M., Hope, A. D., Pittman, A. M., Lashley, T., Canet-Aviles, R., Miller, D. W. et al. (2004). The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease. Brain 127, 420-430.
6. Bencze, K. Z., Kondapalli, K. C., Cook, J. D., McMahon, S., Millan-Pacheco, C., Pastor, N. and Stemmler, T. L. (2006). The structure and function of frataxin. Crit. Rev. Biochem. Mol. Biol. 41, 269-291.
7. Bender, A., Krishnan, K. J., Morris, C. M., Taylor, G. A., Reeve, A. K., Perry, R. H., Jaros, E., Hersheson, J. S., Betts, J., Klopstock, T. et al. (2006). High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat. Genet. 38, 515-517.
8. Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V. and Greenamyre, J. T. (2000). Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3, 1301-1306.
9. Bilen, J. and Bonini, N. M. (2005). Drosophila as a model for human neurodegenerative disease. Annu. Rev. Genet. 39, 153-171.
10. Biskup, S., Moore, D. J., Celsi, F., Higashi, S., West, A. B., Andrabi, S. A., Kurkinen, K., Yu, S. W., Savitt, J. M., Waldvogel, H. J. et al. (2006). Localization of LRRK2 to membranous and vesicular structures in mammalian brain. Ann. Neurol. 60, 557-569.
11. Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C., Squitieri, F., Ibanez, P., Joosse, M. et al. (2003). Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299, 256-259.
12. Bosgraaf, L. and Van Haastert, P. J. (2003). Roc, a Ras/GTPase domain in complex proteins. Biochim. Biophys. Acta 1643, 5-10.
13. Brickley, K., Smith, M. J., Beck, M. and Stephenson, F. A. (2005). GRIF-1 and OIP106, members of a novel gene family of coiled-coil domain proteins: association in vivo and in vitro with kinesin. J. Biol. Chem. 280, 14723-14732.
14. Browne, S. E. and Beal, M. F. (2004). The energetics of Huntington's disease. Neurochem. Res. 29, 531-546.
15. Cabin, D. E., Shimazu, K., Murphy, D., Cole, N. B., Gottschalk, W., McIlwain, K. L., Orrison, B., Chen, A., Ellis, C. E., Paylor, R. et al. (2002). Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J. Neurosci. 22, 8797-8807.
16. Canet-Aviles, R. M., Wilson, M. A., Miller, D. W., Ahmad, R., McLendon, C., Bandyopadhyay, S., Baptista, M. J., Ringe, D., Petsko, G. A. and Cookson, M. R. (2004). The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc. Natl. Acad. Sci. USA 101, 9103-9108.
17. Casari, G., De Fusco, M., Ciarmatori, S., Zeviani, M., Mora, M., Fernandez, P., De Michele, G., Filla, A., Cocozza, S., Marconi, R. et al. (1998). Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 93, 973-983.
18. Casellas, P., Galiegue, S. and Basile, A. S. (2002). Peripheral benzodiazepine receptors and mitochondrial function. Neurochem. Int. 40, 475-486.
19. Cereghetti, G. M. and Scorrano, L. (2006). The many shapes of mitochondrial death. Oncogene 25, 4717-4724.
20. Chan, D. C. (2006). Mitochondrial fusion and fission in mammals. Annu. Rev. Cell Dev. Biol. 22, 79-99.
21. Chandra, S., Fornai, F., Kwon, H. B., Yazdani, U., Atasoy, D., Liu X., Hammer, R. E., Battaglia, G., German, D. C., Castillo. P. E. et al. (2004). Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions. Proc. Natl. Acad. Sci. USA 101, 14966-14971.
22. Chandra, S., Gallardo, G., Fernandez-Chacon, R., Schluter, O. M. and Sudhof, T. C. (2005). Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell 123, 383-396.
23. Chen, H., Detmer, S. A., Ewald, A. J., Griffin, E. E., Fraser, S. E. and Chan, D. C. (2003). Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J. Cell Biol. 160, 189-200.
24. Chen, H., Chomyn, A. and Chan, D. C. (2005). Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J. Biol. Chem. 280, 26185-26192.
25. Chung, K. K., Thomas, B., Li X., Pletnikova, O., Troncoso, J. C., Marsh, L., Dawson, V. L. and Dawson, T. M. (2004). S-nitrosylation of parkin regulates ubiquitination and compromises Parkin's protective function. Science 304, 1328-1331.
26. Ciechanover, A. (1998). The ubiquitin-proteasome pathway: on protein death and cell life. EMBO J. 17, 7151-7160.
27. Cipolat, S., Martins de Brito, O., Dal Zilio, B. and Scorrano, L. (2004). OPA1 requires mitofusin 1 to promote mitochondrial fusion. Proc. Natl. Acad. Sci. USA 101, 15927-15932.
28. Cipolat, S., Rudka, T., Hartmann, D., Costa, V., Serneels, L., Craessaerts, K. Metzger, K., Frezza, C., Annaert, W., D'Adamio, L. et al. (2006). Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling. Cell 126, 163-175.
29. Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A. and Guo, M. (2006). Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441, 1162-1166.
30. Clements, C. M., McNally, R. S., Conti, B. J., Mak, T. W. and Ting, J. P. (2006). DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant trinscriptional master regulator Nrf2. Proc. Natl. Acad. Sci. USA 103, 15091-15096.
31. Conway, K. A., Rochet, J. C., Bieganski, R. M. and Lansbury, P. T., Jr (2001). Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science 294, 1346-1349.
32. Cookson, M. R. (2005). The biochemistry of Parkinson's disease. Annu. Rev. Biochem. 74, 29-52.
33. Cooper, A. A., Gitler, A. D., Cashikar, A., Haynes, C. M., Hill, K. J., Bhullar, B., Liu, K., Xu, K., Strathearn, K. E., Liu, F. et al. (2006). Alpha-synuclem blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 313, 324-328.
34. Cortes-Hernandez, P., Vazquez-Memije, M. E. and Garcia, J. J. (2007). ATP6 homoplasmic mutations inhibit and destabilize the human FIFO-ATP synthase without preventing enzyme assembly and oligomerization. J. Biol. Chem. 282, 1051-1058.
35. Cui, L., Jeong, H., Borovecki, F., Parkhurst, C. N., Tanese, N. and Krainc, D. (2006). Transcriptional repression of PGC-1 alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127, 59-69.
36. Darios, F., Corti, O., Lucking, C. B., Hampe, C., Muriel, M. P., Abbas, N., Gu, W. J., Hirsch, E. C., Rooney, T., Ruberg, M. et al. (2003). Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. Hum. Mol. Genet. 12, 517-526.
37. Dauer, W. and Przedborski, S. (2003). Parkinson's disease: mechanisms and models. Neuron 39, 889-909.
38. Dauer, W., Kholodilov, N., Vida, M., Trillat, A. C., Goodchild, R., Larsen, K. E., Staal, R., Tieu, K., Schmitz, Y., Yuan, C. A. et al. (2002). Resistance of alpha-synuclein null mice to the parkinsonian neurotoxin MPTP. Proc. Natl. Acad. Sci. USA 99, 14524-14529.
39. Delettre, C., Lenaers, G., Griffoin, J. M., Gigarel, N., Lorenzo, C., Belenguer, P., Pelloquin, L., Grosgeorge, J., Turc-Carel, C., Perret, E. et al. (2000). Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat. Genet. 26, 207-210.
40. Di Fonzo, A., Rohe, C. F., Ferreira, J., Chien, H. F., Vacca, L., Stocchi, F., Guedes, L., Fabrizio, E., Manfredi, M., Vanacore, N. et al. (2005). A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet 365, 412-415.
41. Ekstrand, M. L, Terzioglu, M., Gaiter, D., Zhu, S., Hofstetter, C., Lindqvist, E., Thams, S., Bergstrand, A., Hansson, F. S., Triftmovic, A. et al. (2007). Progressive parkinsonism in mice with respiratory-chain-deficient dopamme neurons. Proc. Natl. Acad. Sci. USA 104, 1325-1330.
42. Elleuch, N., Depienne, C., Benomar, A., Hernandez, A. M., Ferrer, X., Fontaine, B., Grid, D., Tallaksen, C. M., Zemmouri, R., Stevanin, G. et al. (2006). Mutation analysis of the paraplegin gene (SPG7) in patients with hereditary spastic paraplegia. Neurology 66, 654-659.
43. Farrer, M., Chan, P., Chen, R., Tan, L., Lincoln, S., Hernandez, D., Forno, L., Gwinn-Hardy, K., Petrucelli, L., Hussey, J. et al. (2001). Lewy bodies and parkinsonism in families with parkin mutations. Ann. Neurol. 50, 293-300.
44. Feany, M. B. and Bender, W. W. (2000). A Drosophila model of Parkinson's disease. Nature 404, 394-308.
45. Fleming, S. M., Fernagut, P. O. and Chesselet, M. F. (2005). Genetic mouse models of parkinsonism: strengths and limitations. NeuroRx 2, 495-503.
46. Fornai, F., Schluter, O. M., Lenzi, P., Gesi, M., Ruffoli, R., Ferrucci, M., Lazzeri, G., Busceti, C. L., Pontarelli, F., Battaglia, G. et al. (2005). Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein. Proc. Natl. Acad. Sci. USA 102, 3413-3418.
47. Frank, S., Gaume, B., Bergmann-Leitner, E. S., Leitner, W. W., Robert, E. G., Catez, F., Smith, C. L. and Youle, R. J. (2001). The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev. Cell 1, 515-525.
48. Fransson, S., Ruusala, A. and Aspenstrom, P. (2006). The atypical Rho GTPases Miro-1 and Miro-2 have essential roles in mitochondrial trafficking. Biochem. Biaphys. Res. Commun. 344, 500-510.
49. Frezza, C., Cipolat, S., Martins de Brito, O., Micaroni, M., Beznoussenko, G. V., Rudka, T., Bartoli, D., Polishuck, R. S., Danial, N. N., De Strooper, B. et al. (2006). OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell 126, 177-189.
50. Galvin, J. E. (2006). Interaction of alpha-synuclein and dopamin metabolites in the pathogenesis of Parkinson's disease: a case for the selective vulnerability of the substantia nigra. Acta Neuropathol. 112, 115-126.
51. Gandhi, S., Muqit, M. M., Stanyer, L., Healy, D. G., Abou-Sleiman, P. M., Hargreaves, I., Heales, S., Ganguly, M., Parsons, L., Lees, A. J. et al. (2006). PINK1 protein in normal human brain and Parkinson's disease. Brain 129, 1720-1731.
52. George, J. M., Jin, H., Woods, W. S. and Clayton, D. F. (1995). Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 15, 361-372.
53. Gilbert, S. L., Zhang, L., Forster, M. L., Anderson, J. R., Iwase, T., Soliven, B., Donahue, L. R., Sweet, H. O., Bronson, R. T., Davisson, M. T. et al. (2006). Trak1 mutation disrupts GABA(A) receptor homeostasis in hypertonic mice. Nat. Genet. 38, 245-250.
54. Glater, E. E., Megeath, L. J., Stowers, R. S. and Schwarz, T. L. (2006). Axonal transport of mitochondria requires milton to recruit kinesin heavy chain and is light chain independent. J. Cell Biol. 173, 545-557.
55. Gloeckner, C. J., Kinkl, N., Schumacher, A., Braun, R. J., O'Neill, E., Meitinger, T., Kolch, W., Prokisch, H. and Ueffing, M. (2006). The Parkinson disease causing LRRK2 mutation 12020T is associated with increased kinase activity. Hum. Mol. Genet. 15, 223-232.
56. Goldberg, M. S., Fleming, S. M., Palacino, J. J., Cepeda, C., Lam, H. A., Bhatnagar, A., Meloni, E. G., Wu, N., Ackerson, L. C., Klapstein, G. J. et al. (2003). Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J. Biol. Chem. 278, 43628-43635.
57. Greene, J. C., Whitworth, A. J., Kuo, L, Andrews, L. A., Feany, M. B. and Pallanck, L. J. (2003). Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc. Natl. Acad. Sci. USA 100, 4078-4083.
58. Greene, J. C., Whitworth, A. J., Andrews, L. A., Parker, T. J. and Pallanck, L. J. (2005). Genetic and genomic studies of Drosophila Parkin mutants implicate oxidative stress and innate immune responses in pathogenesis. Hum. Mol. Genet. 14, 799-811.
59. Greggio, E., Jain, S., Kingsbury, A., Bandopadhyay, R., Lewis, P., Kaganovich, A., van der Brug, M. P., Beilina, A., Blackinton, J., Thomas, K. J. et al. (2006). Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. Neurobiol. Dis. 23, 329-341.
60. Guo, X., Macleod, G. T., Wellington, A., Hu, F., Panchumarthi, S., Schoenfield, M., Marin, L., Chariton, M. P., Atwood, H. L. and Zinsmaier, K. E. (2005). The GTPase dMiro is required for axonal transport of mitochondria to Drosophila synapses. Neuron 47, 379-393.
61. Hatano, Y., Li, Y., Sato, K., Asakawa, S., Yamamura, Y., Tomiyama, H., Yoshino, H., Asahina, M., Kobayashi, S., Hassin-Baer, S. et al. (2004). Novel PINK1 mutations in early-onset parkinsonism. Ann. Neurol. 56, 424-427.
62. Hayflick, S. J. (2003). Unraveling the Hallervorden-Spatz syndrome: pantothenate kinase-associated neurodegeneration is the name. Curr. Opin. Pediatr. 15, 572-577.
63. Hoepken, H. H., Gispert, S., Morales, B., Wingerter, O., Del Turco, D., Mulsch, A., Nussbaum, R. L., Muller, K., Drose, S., Brandt, U. et al. (2007). Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6. Neurobiol. Dis. 25, 401-411.
64. Ihara, M., Tomimoto, H., Kitayama, H., Morioka, Y., Akiguchi, L, Shibasaki, H., Noda, M. and Kinoshita, M. (2003). Association of the cytoskeletal GTP-binding protein Sept4/145 with cytoplasmic inclusions found in Parkinson's disease and other synucleinopathies. J. Biol. Chem. 278, 24095-24102.
65. Ihara, M., Yamasaki, N., Hagiwara, A., Tanigaki, A., Kitano, A., Hikawa, R., Tomimoto, H., Noda, M., Takanashi, M., Mori, H. et al. (2007). Sept4, a component of presynaptic scaffold and lewy bodies, is required for the suppression of alpha-Synuclein neurotoxicity. Neuron 53, 519-533.
66. Itier, J. M., Ibanez, P., Mena, M. A., Abbas, N., Cohen-Salmon, C., Bohme, G. A., Laville, M., Pratt, J., Corti, O., Pradier, L. et al. (2003). Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. Hum. Mol. Genet. 12, 2277-2291.
67. Junn, E., Taniguchi, H., Jeong, B. S., Zhao, X., Ichijo, H. and Mouradian, M. M. (2005). Interaction of DJ-I with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death. Proc. Natl. Acad. Sci. USA 102, 9691-9696.
68. Kachergus, J., Mata, I. F., Hulihan, M., Taylor, J. P., Lincoln, S., Aasly, J., Gibson, J. M., Ross, O. A., Lynch, T., Wiley, J. et al. (2005). Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations. Am. J. Hum. Genet. 76, 672-680.
69. Kijima, K., Numakura, C., Izumino, H., Umetsu, K., Nezu, A., Shiiki, T., Ogawa, M., Ishizaki, Y., Kitamura, T., Shozawa, Y. et al. (2005). Mitochondrial GTPase mitofusin 2 mutation in Charcot-Marie-Tooth neuropathy type 2A. Hum. Genet. 116, 23-27.
70. Kim, R. H., Smith, P. D., Aleyasin, H., Hayley, S., Mount, M. P., Pownall, S., Wakeham, A., You-Ten, A. J., Kalia, S. K., Horne, P. et al. (2005). Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc. Natl. Acad. Sci. USA 102, 5215-5220.
71. Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y. and Shimizu, N. (1998). Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605-608.
72. Klivenyi, P., Siwek, D., Gardian, G., Yang, L., Starkov, A., Cleren, C., Ferrante, R. J., Kowall, N. W., Abeliovich, A. and Beal, M. F. (2006). Mice lacking alpha-synuclein are resistant to mitochandrial toxins. Neurobiol. Dis. 21, 541-548.
73. Koshiba, T., Detmer, S. A., Kaiser, J. T., Chen, H., McCaffery, J. M. and Chan, D. C. (2004). Structural basis of mitochondrial tethering by mitofusin complexes. Science 305, 858-862.
74. Koutnikova, H., Campuzano, V., Foury, F., Dolle, P., Cazzalini, O. and Koenig, M. (1997). Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin. Nat. Genet. 16, 345-351.
75. Kraytsberg, Y., Kudryavtseva, E., McKee, A. C., GeWa, C., Kowall, N. W. and Khrapko, K. (2006). Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat. Genet. 38, 518-520.
76. Langston, J. W., Ballard, P., Tetrud, J. W. and Irwin, I. (1983). Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979-980.
77. Lashuel, H. A., Hartley, D., Petre, B. M., Walz, T. and Lausbury, P. T., Jr (2002). Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 418, 291.
78. LaVoie, M. J., Ostaszewski, B. L., Weihofen, A., Schlossmacher, M. G. and Selkoe, D. J. (2005). Dopamine covalently modifies and functionally inactivates parkin. Nat. Med. 11, 1214-1221.
79. Lee, V. M., Goedert, M. and Trojanowski, J. Q. (2001). Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24, 1121-1159.
80. Lee, Y. J., Jeong, S. Y., Karbowski, M., Smith, C. L. and Youle, R. J. (2004). Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis. Mol. Biol. Cell 15, 5001-5011.
81. Li, Z., Okamoto, K., Hayashi, Y. and Sheng, M. (2004). The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 119, 873-887.
82. Liu, J., Lillo, C., Jonsson, P. A., Vande Velde, C., Ward, C. M., Miller, T. M., Subramaniam, J. R., Rothstein, J. D., Marklund, S., Andersen, P. M. et al. (2004). Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron 43, 5-17.
83. Lotharius, J., Barg, S., Wiekop, P., Lundberg, C., Raymon, H. K. and Brundin, P. (2002). Effect of mutant alpha-synuclein on dopanime homeostasis in a new human mesencephalic cell line. J. Biol. Chem. 277, 38884-38894.
84. Lucking, C. B., Durr, A., Bonifati, V., Vaughan, J., De Michele, G., Gasser, T., Harhangi, B. S., Meco, G., Denefte, P., Wood, N. W. et al. (2000). Association between early-onset Parkinson's disease and mutations in the parkin gene. N. Engl. J. Med. 342, 1560-1567.
85. Luoma, P., Melberg, A., Rinne, J. O., Kaukonen, J. A., Nupponen, N. N., Chalmers, R. M., Oldfors, A., Rautakorpi, L, Peltonen, L., Majamaa, K. et al. (2004). Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet 364, 875-882.
86. Macleod, D., Dowman, J., Hammond, R., Leete, T., Inoue, K. and Abeliovich, A. (2006). The familial Parkinsonism gene LRRK2 regulates neurite process morphology. Neuron 52, 587-593.
87. Manning-Bog, A. B., McCormack, A. L., Li, J., Uversky, V. N., Fink, A. L. and Di Monte, D. A. (2002). The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein. J. Biol. Chem. 277, 1641-1644.
88. Mata, I. F., Wedemeyer, W. J., Farrer, M. J., Taylor, J. P. and Gallo, K. A. (2006). LRRK2 in Parkinson's disease: protein domains and functional insights. Trends Neurosci. 29, 286-293.
89. Menzies, F. M., Yenisetti, S. C. and Min, K. T. (2005). Roles of Drosophila DJ-1 in survival of dopaminergic neurons and oxidative stress. Curr. Biol. 15, 1578-1582.
90. Meulener, M., Whitworth, A. J., Armstrong-Gold, C. E., Rizzu, P., Heutink, P., Wes, P. D., Pallanck, L. J. and Bonini, N. M. (2005). Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson's disease. Curr. Biol. 15, 1572-1577.
91. Miller, D. W., Ahmad, R., Hague, S., Baptista, M. J., Canet-Aviles, R., McLendon, C., Carter, D. M., Zhu, P. P., Stadler, J., Chandran, J. et al. (2003). L166P mutant DJ-1, causative for recessive Parkinson's disease, is degraded through the ubiquitin-proteasome system. J. Biol. Chem. 278, 36588-36595.
92. Mitsumoto, A. and Nakagawa, Y. (2001). DJ-1 is an indicator for endogenous reactive oxygen species elicited by endotoxin. Free Radic. Res. 35, 885-893.
93. Moore, D. J. (2006). Parkin: a multifaceted ubiquitin ligase. Biochem. Soc. Trans. 34, 749-753.
94. Moore,D. J., Zhang, L., Dawson, T. M. and Dawson, V. L. (2003). A missense mutation (L166P) in DJ-1, linked to familial Parkinson's disease, confers reduced protein stability and impairs homo-oligomerization. J. Neurochem. 87, 1558-1567.
95. Moore, D. J., West, A. B., Dawson, V. L. and Dawson, T. M. (2005a). Molecular pathophysiology of Parkinson's disease. Annu. Rev. Neurosci. 28, 57-87.
96. Moore, D. J., Zhang, L., Troncoso, J., Lee, M. K., Hattori, N., Mizuno, Y., Dawson, T. M. and Dawson, V. L. (2005b). Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress. Hum. Mol. Genet. 14, 71-84.
97. Mori, H., Kondo, T., Yokochi, M., Matsumine, H., Nakagawa-Hattori, Y., Miyake, T., Suda, K. and Mizuno, Y. (1998). Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q. Neurology 51, 890-892.
98. Mukherjee, S. and Das, S. K. (1989). Subcellular distribution of "peripheral type" binding sites for [3H]Ro5-4864 in guinea pig lung. Localization to the mitochondrial inner membrane. J. Biol. Chem. 264, 16713-16718.
99. Nichols, W. C., Pankratz, N., Hernandez, D., Paisan-Ruiz, C., Jain, S., Halter, C. A., Michaels, V. E., Reed, T., Rudolph, A., Shults, C. W. et al. (2005). Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. Lancet 365, 410-412.
100. Niemann, A., Ruegg, M., La Padula, V., Schenone, A. and Suter, U. (2005). Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network: new implications for Charcot-Marie-Tooth disease. J. Cell Biol. 170, 1067-1078.
101. Nolden, M., Ehses, S., Koppen, M., Bernacchía, A., Rugarti, E. I. and Langer, T. (2005). The m-AAA protease defective in hereditary spastic paraplegia controls ribosome assembly in mitochondria. Cell 123, 277-289.
102. Obeso, J. A., Rodriguez-Oroz, M. C., Rodriguez, M., Lanciego, J. L., Artieda, J., Gonzalo, N. and Olanow, C. W. (2000). PaLhophysiology of the basal ganglia in Parkinson's disease. Trends Neurosci. 23, S8-S19.
103. Olichon, A., Emorine, L. J., Descoins, E., Pelloquin, L., Brichese, L., Gas, N., Guillou, E., Delettre, C., Valette, A., Hamel, C. P. et al. (2002). The human dynamin-related protein OPA1 is anchored to the mitochondrial inner membrane facing the inter-membrane space. FEBS Lett. 523, 171-176.
104. Olichon, A., Guillou, E., Delettre, C., Landes, T., Arnaune-Pefloquin, L., Emorine, L. J., Mils, V., Daloyau, M., Hamel, C., Amati-Bonneau, P. et al. (2006). Mitochondrial dynamics and disease, OPA1. Biochim. Biophys. Acta 1763, 500-509.
105. Olzmann, J. A., Brown, K., Wilkinson, K. D., Rees, H. D., Huai, Q., Ke H., Levey, A. L, Li, L. and Chin, L. S. (2004). Familial Parkinson's disease-associated L166P mutation disrupts DJ-1 protein folding and function. J. Biol. Chem. 279, 8506-8515.
106. Orth, M., Tabrizi, S. J., Schapira, A. H. and Cooper, J. M. (2003). Alpha-synuclein expression in HEK293 cells enhances the mitochondrial sensitivity to rotenone. Neurosci. Lett. 351, 29-32.
107. Palacino, J. J., Sagi, D., Goldberg, M. S., Krauss, S., Motz, C., Wacker, M., Klose, J. and Shen, J. (2004). Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J. Biol. Chem. 279, 18614-18622.
108. Park, J., Kim, S. Y., Cha, G. H., Lee, S. B., Kim, S. and Chung, J. (2005). Drosophila DJ-1 mutants show oxidative stress-sensitive locomotive dysfunction. Gene 361, 133-139.
109. Park, J., Lee, S. B., Lee, S., Kim, Y.9 Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J. M. et al. (2006). Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441, 1157-1161.
110. Perez, F. A. and Palmiter, R. D. (2005). Parkin-deficient mice are not a robust model of parkinsonism. Proc. Natl. Acad. Sci. USA 102, 2174-2179.
111. Petit, A., Kawarai, T., Paitel, E., Sanjo, N., Maj, M., Scheid, M., Chen, F., Gu, Y., Hasegawa, H., Salehi-Rad, S. et al. (2005). Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations. J. Biol. Chem. 280, 34025-34032.
112. Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R. et al. (1997). Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047.
113. Pyle, A., Foltynie, T., Tiangyou, W., Lambert, C., Keers, S. M., Allcock, L. M., Davison, J., Lewis, S. J., Perry, R. H., Barker, R. et al. (2005). Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD. Ann. Neurol. 57, 564-567.
114. Ramsey, C. P., Glass, C. A., Montgomery, M. B., Lindl, K. A., Ritson, G. P., Chia, L. A., Hamilton, R. L., Chu, C. T. and Jordan-Sciutto, K. L. (2007). Expression of Nrf2 in neurodegenerative diseases. J. Neuropathol. Exp. Neurol. 66, 75-85.
115. Rossignol, R., Faustin, B., Rocher, C., Malgat, M., Mazat, J. P. and Letellier, T. (2003). Mitochondrial threshold effects. Biochem. J. 370, 751-762.
116. Rotig, A., de Lonlay, P., Chretien, D., Foury, F., Koenig, M., Sidi, D., Munnich, A. and Rustin, P. (1997). Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat. Genet. 17, 215-217.
117. Rugarli, E. I. and Langer, T. (2006). Translating m-AAA protease function in mitochondria to hereditary spastic paraplegia. Trends Mol. Med. 12, 262-269.
118. Sasaki, S., Shirata, A., Yamane, K. and Iwata, M. (2004). Parkin-positive autosomal recessive juvenile Parkinsomsm with alpha-synuclein-positive inclusions. Neurology 63, 678-682.
119. Savitt, J. M., Dawson, V. L. and Dawson, T. M. (2006). Diagnosis and treatment of Parkinson disease: molecules to medicine. J. Clin. Invest. 116, 1744-1754.
120. Schluter, O. M., Fornai, F., Alessandri, M. G., Takamori, S., Geppert, M., Jahn, R. and Sudhof, T. C. (2003). Role of alpha-synuclein in 1-methyl-4-phenyl-12,3,6-tetrahydropyridine-induced parkinsonism in mice. Neuroscience 118, 985-1002.
121. Sherer, T. B., Kim, J. H., Betarbet, R. and Greenamyre, J. T. (2003). Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation. Exp. Neurol. 179, 9-16.
122. Shimura, H., Hattori, N., Kuhn, S., Mizuno, Y., Asakawa, S, Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K. et al. (2000). Familial Parkinson disease gene product, Parkin, is a ubiquitin-protein ligase. Nat. Genet. 25, 302-305.
123. Silvestri, L., Caputo, V., Bellacchio, E., Atorino, L., Dallapiccola, B., Valente, E. M. and Casari, G. (2005). Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Hum. Mol. Genet. 14, 3477-3492.
124. Smith, W. W., Pei, Z., Jiang H., Moore, D. J., Liang, Y., West, A. B., Dawson, V. L., Dawson, T. M. and Ross, C. A. (2005). Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration. Proc. Natl. Acad. Sci. USA 102, 18676-18681.
125. Smith, W. W., Pei, Z., Jiang, H., Dawson, V. L., Dawson, T. M. and Ross, C. A. (2006). Kinase activity of mutant LRRK2 mediates neuronal toxicity. Nat. Neurosci. 9, 1231-1233.
126. Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M. and Goedert, M. (1998). alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc. Natl. Acad. Sci. USA 95, 6469-6473.
127. St-Pierre, J., Drori, S., Uldry, M., Silvaggi, J. M., Rhee, J., Jager, S., Handschin, C., Zheng, K., Lin, J., Yang, W. et al. (2006). Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127, 397-408.
128. Stowers, R. S., Megeath, L. J., Gorska-Andrzejak, J., Meinertzhagen, I. A. and Schwarz, T. L. (2002). Axonal transport of mitochondria to synapses depends on milton, a novel Drosophila protein. Neuron 36, 1063-1077.
129. Strauss, K. M., Martins, L. M., Plun-Favreau, H., Marx, F. P., Kautzmann, S., Berg, D., Gasser, T., Wszolek, Z., Muller, T., Bornemann, A. et al. (2005). Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Hum. Mol. Genet. 14, 2099-2111.
130. Taira, T., Saito, Y., Niki, T., Iguchi-Ariga, S. M., Takahashi, K. and Ariga, H. (2004). DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep. 5, 213-218.
131. Takahashi, K., Taira, T., Niki, T., Seino, C., Iguchi-Ariga, S. M. and Ariga, H. (2001). DJ-1 positively regulates the androgen receptor by impairing the binding of PIASx alpha to the receptor. J. Biol. Chem. 276, 37556-37563.
132. Truant, R., Atwal, R. and Burtnik, A. (2006). Hypothesis: huntingtin may function in membrane association and vesicular trafficking. Biochem. Cell Biol. 84, 912-917.
133. Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy D. G. et al. (2004a). Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304, 1158-1160.
134. Valente, E. M., Salvi, S., Ialongo, T., Marongiu, R., Elia, A. E., Caputo, V., Romito, L., Albanese, A., Dallapiccola, B. and Bentivoglio, A. R. (2004b). PINK1 mutations are associated with sporadic early-onset parkinsonism. Ann. Neural. 56, 336-341.
135. van der Walt, J. M., Nicodemus, K. K., Martin, E. R., Scott, W. K., Nance, M. A., Watts, R. L., Hubble, J. P., Haines, J. L., Koller, W. C., Lyons, K. et al. (2003). Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am. J. Hum. Genet. 72, 804-811.
136. Verstreken, P., Ly C. V., Venken, K. J., Koh, T. W., Zhou, Y. and Bellen, H. J. (2005). Synaptic mitochondria are critical for mobilization of reserve pool vesicles at Drosophila neuromuscular junctions. Neuron 47, 365-378.
137. Vila, M. and Przedborski, S. (2003). Targeting programmed cell death in neurodegenerative diseases. Nat. Rev. Neurosci. 4, 365-375.
138. Votruba, M. (2004). Molecular genetic basis of primary inherited optic neuropathies. Eye 18, 1126-1132.
139. West, A. B. and Maidment, N. T. (2004). Genetics of parkin-linked disease. Hum. Genet. 114, 327-336.
140. West, A. B., Moore, D. J., Biskup, S., Bugayenko, A., Smith, W. W., Ross, C. A., Dawson, V. L. and Dawson, T. M. (2005). Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc. Natl. Acad. Sci. USA 102, 16842-16847.
141. West, A. B., Moore, D. J., Choi, C., Andrabi, S. A., Li, X., Dikeman, D., Biskup, S., Zhang, Z., Lim, K. L., Dawson, V. L. et al. (2007). Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity. Hum. Mol. Genet. 16, 223-232.
142. Whitworth, A. J., Theodore, D. A., Greene, J. C., Benes, H., Wes, P. D. and Pallanck, L. J. (2005). Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease. Proc. Natl. Acad. Sci. USA 102, 8024-8029.
143. Wilson, R. B. (2006). Iron dysregulation in Friedreich ataxia. Semin. Pediatr. Neurol. 13, 166-175.
144. Wilson, R. B. and Roof, D. M. (1997). Respiratory deficiency due to loss of mitochondrial DNA in yeast lacking the frataxin homologue. Nat. Genet. 16, 352-357.
145. Xu, J., Zhong, N., Wang, H., Elias, J. E., Kim, C. Y., Woldman, L, Pifl, C., Gygi, S. P., Geula, C. and Yankner, B. A. (2005). The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis. Hum. Mol. Genet. 14, 1231-1241.
146. Yang, Y., Gehrke, S., Haque, M. E., Imai, Y., Kosek, J., Yang, L., Beal, M. F., Nishimura, I., Wakamatsu, K., Ito, S. et al. (2005). Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling. Proc. Natl. Acad. Sci. USA 102, 13670-13675.
147. Yang, Y, Gehrke, S., Imai, Y., Huang, Z., Ouyang, Y., Wang, J. W., Yang, L., Beal, M. F., Vogel, H. and Lit, B. (2006). Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc. Natl. Acad. Sci. USA 103, 10793-10798.
148. Yokota, T., Sugawara, K., Ito, K., Takahashi, R., Ariga, H. and Mizusawa, H. (2003). Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition. Biochem. Biophys. Res. Commun. 312, 1342-1348.
149. Yoon, Y., Krueger, E. W., Oswald, B. J. and McNiven, M. A. (2003). The mitochondrial protein hFis1 regulates mitochoadrial fission in mammalian cells through an interaction with the dynamin-like protein DLP1. Mol. Cell. Biol. 23, 5409-5420.
150. Yu, T., Fox, R. J., Burwell, L. S. and Yoon, Y. (2005). Regulation of mitochondrial fission and apoptosis by the mitochondrial outer membrane protein hFis1. J. Cell Sci. 118, 4141-4151.
151. Zuchner, S., Mersiyanova, I. V., Muglia, M., Bissar-Tadmouri, N., Rochelle, J., Dadali, E. L., Zappia, M., Neils, E., Patitucci, A., Senderek, J. et al. (2004). Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat. Genet. 36, 449-451.